RDInvesting Provides Stock Research on Advanced Energy Industries and MEMC Electronic Materials
Continue ReadingTag: research-driven-investing
U.S. Food and Drug Administration Approved 30% More Drugs in 2012
RDInvesting Provides Stocks Research on Celldex Therapeutics and Peregrine Pharmaceuticals
Continue Reading
Centers for Medicare and Medicaid Services Projects Health Care Spending to Grow From $2.8 Trillion to $4.8 Trillion by 2021
Research Driven Investing Provides Stocks Research on Centene and Molina Healthcare
Continue Reading
Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry-s Success
RDInvesting Provides Stocks Research on Alexza Pharmaceuticals and Savient Pharmaceuticals
Continue Reading
FDA Approved a Total of 39 New Drugs in 2012 — Fifteen Year High
Research Driven Investing Provides Stocks Research on StemCells and ZIOPHARM Oncology
Continue Reading
First Solar and SunPower Surge After Receiving “Buy” Rating From CitiGroup
RDInvesting Provides Stock Research on First Solar and SunPower
Continue Reading
Biotechnology Industry Soars in 2012 as FDA Drug Approvals at a 15-Year High
Research Driven Investing Provides Stocks Research on ArQule and BioCryst Pharmaceuticals
Continue Reading
Solar Industry Impressing Investors With Gains After Dismal 2012
RDInvesting Provides Stock Research on Trina Solar and Yingli Green Energy
Continue Reading
Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry-s Success
Research Driven Investing Provides Stocks Research on ImmunoGen and Omeros
Continue Reading
U.S. Food and Drug Administration Approved 30% More Drugs in 2012
Research Driven Investing Provides Stocks Research on Athersys and Rexahn Pharmaceuticals
Continue Reading